Day One Biopharmaceuticals, Inc. — 10-Q Filings
14 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Day One Biopharmaceuticals, Inc. (DAWN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Day One Biopharmaceuticals, Inc. has filed 14 10-Q documents with the SEC since 2021. To view all SEC filings by Day One Biopharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14D9
SC TO-C
SC TO-T
SC TO-T/A
SC14D9C
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-264649 | Nov 4, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-103012 | Aug 5, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-064436 | May 6, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-118958 | Oct 30, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-089945 | Aug 2, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-053612 | May 6, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-059485 | Nov 6, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-039118 | Aug 7, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-016046 | May 1, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-022667 | Nov 7, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-014859 | Aug 4, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-009734 | May 12, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-003496 | Nov 8, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001193125-21-242039 | Aug 10, 2021 | Jun 30, 2021 |